-+ 0.00%
-+ 0.00%
-+ 0.00%

*Revolution Medicines: Steve Kelsey, Pres, R&D, to Transition to Senior Advisor to CEO Ahead of Planned Retirement in Jan 2027 >RVMD

Dow Jones·06/22/2026 12:00:00

Please log in to view news